Status:
UNKNOWN
Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation
Lead Sponsor:
Hannover Medical School
Collaborating Sponsors:
Roche Pharma AG
Conditions:
Exercise Capacity
Heart Transplantation
Eligibility:
All Genders
18-67 years
Phase:
NA
Brief Summary
A prospective, interventional rehabilitation program was initiated to improve exercise tolerance and psychosocial functioning in patients after heart transplantation (HTx) and to evaluate long-term ef...
Eligibility Criteria
Inclusion
- Heart transplant (6-9 mts post Tx) stabile health condition at study entry (pt stays within home environment)
- Age ≥ 18 yrs
- Sufficient language skills to answer questionnaire
- Follow-up at our center
- Willingness to participate by written informed consent
Exclusion
- TVP diagnosis before study inclusion
- Episodes of recurrent acute rejections
- Medical contra-indication for regular exercise ergometer training
- Malignancy
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT00752336
Start Date
January 1 2002
End Date
September 1 2009
Last Update
September 15 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.